Submission for OMB Review; 30-Day Comment Request; NCI Genomic Data Commons (GDC) Data Submission Request Form (National Cancer Institute), 14173-14174 [2023-04628]

Download as PDF 14173 Federal Register / Vol. 88, No. 44 / Tuesday, March 7, 2023 / Notices Number of respondents Form name Number of responses per respondent Total burden hours Rural Health Network Development Planning Program Performance Improvement Measurement System .......... 23 1 23 1 23 Total .............................................................................. 23 ........................ 23 ........................ 23 HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: March 2, 2023. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–04621 Filed 3–6–23; 8:45 am] BILLING CODE 4140–01–P Maria G. Button, Director, Executive Secretariat. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2023–04585 Filed 3–6–23; 8:45 am] BILLING CODE 4165–15–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. ddrumheller on DSK120RN23PROD with NOTICES1 Average burden per response (in hours) Total responses Name of Committee: National Institute on Aging Special Emphasis Panel; Dementia Care. Date: March 28, 2023. Time: 9:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Dario Dieguez, Ph.D., Scientific Review Officer, National Institutes of Health, National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892, (301) 827–3101, dario.dieguez@nih.gov. VerDate Sep<11>2014 19:49 Mar 06, 2023 Jkt 259001 Submission for OMB Review; 30-Day Comment Request; NCI Genomic Data Commons (GDC) Data Submission Request Form (National Cancer Institute) AGENCY: National Institutes of Health, HHS. ACTION: Notice. In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. DATES: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or using the search function. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Jean Claude Zenklusen, Ph.D., Scientific Program Director, Center for Cancer Genomics SUMMARY: PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 (CCG), National Cancer Institute, Building 31 Room 3A20, 31 Center Drive, Bethesda MD 20814 or call the non-toll-free number 301–781–3409 or Email your request, including your address to: Jean.Zenklusen@nih.gov. SUPPLEMENTARY INFORMATION: This proposed information collection was previously published in the Federal Register on November 7, 2022, page 67049 (Vol. 87 No. 215 FR 67049 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. Proposed Collection: NCI Genomic Data Commons (GDC) Data Submission Request Form, 0925–0752, Expiration Date 3/31/2023, EXTENSION, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of the NCI Genomic Data Commons (GDC) Data Submission Request Form is to provide a vehicle for investigators to request the submission of their cancer genomic data into the GDC in support of data sharing. The purpose is also to provide a mechanism for the GDC Data Submission Review Committee to review and assess the data submission request for applicability to the GDC mission. The scope of the form involves obtaining information from investigators that: (1) would like to submit data about their study into the GDC, (2) are affiliated with studies that adhere to GDC data submission conditions. The benefits of the collection are that it provides the needed information for investigators to understand the types of E:\FR\FM\07MRN1.SGM 07MRN1 14174 Federal Register / Vol. 88, No. 44 / Tuesday, March 7, 2023 / Notices studies and data that the GDC supports and allows for a standard mechanism for the GDC to assess incoming data submission requests. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 50 hours. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent Average time per response (in hours) Total annual burden hour Investigator ...................................................................................................... 200 1 15/60 50 Total .......................................................................................................... ........................ 200 ........................ 50 Dated: March 2, 2023. Diane Kreinbrink, Project Clearance Liaison, National Cancer Institute, National Institutes of Health. [FR Doc. 2023–04628 Filed 3–6–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should register at: https://public.csr.nih.gov/ AboutCSR/Organization/ CSRAdvisoryCouncil/Registration. The meeting can be viewed remotely via the NIH Videocasting website: https://videocast.nih.gov/watch=49156. ddrumheller on DSK120RN23PROD with NOTICES1 Number of responses per respondent Name of Committee: Center for Scientific Review Advisory Council. Date: March 27, 2023. Time: 10:00 a.m. to 3:00 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, 6701 Rockledge Drive, Conference Room 160A, Bethesda, MD 20892. Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–9159, reedbr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the VerDate Sep<11>2014 19:49 Mar 06, 2023 Jkt 259001 name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has stringent procedures for entrance into NIH federal property. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Additional Health and Safety Guidance: Before attending a meeting at an NIH facility, it is important that visitors review the NIH COVID–19 Safety Plan at https:// ors.od.nih.gov/sr/dohs/safety/NIH-covid-19safety-plan/Pages/default.aspx for information about requirements and procedures for entering NIH facilities, especially when the COVID–19 community level is medium. If the COVID–19 level is high, the meeting will be held virtually. In addition, the Safer Federal Workforce website has FAQs for visitors at https:// www.saferfederalworkforce.gov/faq/visitors/. Please note that if an individual has a COVID–19 diagnosis within 10 days of the meeting, that person must attend virtually. (For more information please read NIH’s Requirements for Persons after Exposure at https://ors.od.nih.gov/sr/dohs/safety/NIHcovid-19-safety-plan/COVID-assessmenttesting/Pages/persons-after-exposure.aspx and What Happens When Someone Tests Positive at https://ors.od.nih.gov/sr/dohs/ safety/NIH-covid-19-safety-plan/COVIDassessment-testing/Pages/test-positive.aspx.) Anyone from the public can attend the meeting virtually via the NIH Videocasting website (https://videocast.nih.gov). Please continue checking these websites, in addition to the committee website listed below, for the most up-to-date guidance as the meeting date approaches. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/AboutCSR/Organization/ CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) PO 00000 Frm 00061 Fmt 4703 Sfmt 4703 Dated: March 1, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–04622 Filed 3–6–23; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF THE INTERIOR U.S. Geological Survey [GX23EE000101100] Public Meeting of the National Geospatial Advisory Committee Department of the Interior. Notice of public meeting. AGENCY: ACTION: In accordance with the Federal Advisory Committee Act (FACA) of 1972, the U.S. Geological Survey (USGS) is publishing this notice to announce that a Federal Advisory Committee meeting of the National Geospatial Advisory Committee (NGAC) will take place. DATES: The webinar meeting will be held on Tuesday, April 11, 2023, from 1 p.m. to 5 p.m. and on Wednesday, April 12, 2023, from 1 p.m. to 5 p.m. (Eastern Standard Time). ADDRESSES: The meeting will be held on-line and via teleconference. Instructions for accessing the meeting will be posted at www.fgdc.gov/ngac. Comments can be sent by email to gsfaca@usgs.gov. FOR FURTHER INFORMATION CONTACT: Mr. John Mahoney, Federal Geographic Data Committee (FGDC), USGS, by mail at 909 First Avenue, Room 703, Seattle, WA 98104; or by email at jmahoney@ usgs.gov; or by telephone at (206) 375– 2565. SUPPLEMENTARY INFORMATION: This meeting is being held under the provisions of the FACA of 1972 (5 U.S.C., Appendix 10), the Government in the Sunshine Act of 1976 (5 U.S.C. 552B, as amended), and 41 CFR 102– 3.140 and 102–3.150. SUMMARY: E:\FR\FM\07MRN1.SGM 07MRN1

Agencies

[Federal Register Volume 88, Number 44 (Tuesday, March 7, 2023)]
[Notices]
[Pages 14173-14174]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-04628]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-Day Comment Request; NCI Genomic 
Data Commons (GDC) Data Submission Request Form (National Cancer 
Institute)

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the 
National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below.

DATES: Comments regarding this information collection are best assured 
of having their full effect if received within 30 days of the date of 
this publication.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or using the search function.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the data collection plans and 
instruments, contact: Jean Claude Zenklusen, Ph.D., Scientific Program 
Director, Center for Cancer Genomics (CCG), National Cancer Institute, 
Building 31 Room 3A20, 31 Center Drive, Bethesda MD 20814 or call the 
non-toll-free number 301-781-3409 or Email your request, including your 
address to: [email protected].

SUPPLEMENTARY INFORMATION: This proposed information collection was 
previously published in the Federal Register on November 7, 2022, page 
67049 (Vol. 87 No. 215 FR 67049 and allowed 60 days for public comment. 
No public comments were received. The purpose of this notice is to 
allow an additional 30 days for public comment.
    The National Cancer Institute (NCI), National Institutes of Health, 
may not conduct or sponsor, and the respondent is not required to 
respond to, an information collection that has been extended, revised, 
or implemented on or after October 1, 1995, unless it displays a 
currently valid OMB control number.
    In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction 
Act of 1995, the National Institutes of Health (NIH) has submitted to 
the Office of Management and Budget (OMB) a request for review and 
approval of the information collection listed below.
    Proposed Collection: NCI Genomic Data Commons (GDC) Data Submission 
Request Form, 0925-0752, Expiration Date 3/31/2023, EXTENSION, National 
Cancer Institute (NCI), National Institutes of Health (NIH).
    Need and Use of Information Collection: The purpose of the NCI 
Genomic Data Commons (GDC) Data Submission Request Form is to provide a 
vehicle for investigators to request the submission of their cancer 
genomic data into the GDC in support of data sharing. The purpose is 
also to provide a mechanism for the GDC Data Submission Review 
Committee to review and assess the data submission request for 
applicability to the GDC mission. The scope of the form involves 
obtaining information from investigators that: (1) would like to submit 
data about their study into the GDC, (2) are affiliated with studies 
that adhere to GDC data submission conditions. The benefits of the 
collection are that it provides the needed information for 
investigators to understand the types of

[[Page 14174]]

studies and data that the GDC supports and allows for a standard 
mechanism for the GDC to assess incoming data submission requests.
    OMB approval is requested for 3 years. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 50 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of     Average time
               Type of respondent                    Number of     responses per   per response    Total annual
                                                    respondents     respondent      (in hours)      burden hour
----------------------------------------------------------------------------------------------------------------
Investigator....................................             200               1           15/60              50
                                                 ---------------------------------------------------------------
    Total.......................................  ..............             200  ..............              50
----------------------------------------------------------------------------------------------------------------


    Dated: March 2, 2023.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer Institute, National 
Institutes of Health.
[FR Doc. 2023-04628 Filed 3-6-23; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.